Investor Relations

Harvard Bioscience is a global developer, manufacturer and marketer of a broad range of specialized products, primarily apparatus and scientific instruments used to advance life science research and regenerative medicine at pharmaceutical and biotechnology companies, universities and government laboratories worldwide. We sell our products to... More >> Recent Releases Aug 23, 2010 Harvard Bioscience, Inc. Acquires Coulbourn Instruments -- a Leading Manufacturer of Systems Used in the Behavioral Research Market Aug 5, 2010 HBIO Reports Second Quarter 2010 Revenue Growth of 44% Over Second Quarter 2009 View all releases » Events & Presentations Aug 5, 2010 at 11:00 AM ET Q2 2010 Harvard Bioscience, Inc. Earnings Conference Call Jun 10, 2010 at 9:30 AM ET Jefferies 2010 Global Life Sciences Conference View all events & presentations »

HBIO : NASDAQ 3 Mo.6 Mo.1 Yr. Stock Quote Harvard Bioscience, Inc. Price: 3.44 Change: 0.06 Day High: 3.44 Day Low: 3.40 Volume: 9,900 Delayed at least 20 minutes. Provided by eSignal. Featured Reports 2009 Annual Report (online version)

Disclaimer:
The information contained within this and other Harvard Bioscience Web pages should be deemed accurate and current as of the date of the most recent update, or if no update information has been provided, the date of issuance. Harvard Bioscience assumes no responsibility for any misincurrances or misstatements which occur as the result of the reading of dated material. Users are strongly encouraged to check dates of issuance and most recent update of any information contained within, or linked to, Harvard Bioscience’s web site. For Harvard Bioscience’s most current information please reference Harvard Bioscience public filings with the Securities and Exchange Commission located at http://www.sec.gov.